Learn about the most advanced sarcoidosis investigational treatment, efzofitimod. Gain an understanding of efzofitimod and its novel and differentiated mechanism of action. Plus, review the efzofitimod Ph1b/2a trial results, and hear about the EFZO-FIT Phase 3 trial design, including how to participate through the patient referral network program.
Email address contact: efzofit@atyrpharma.com
Website: www.efzofit.com
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.